News Snapshot:
Taipei, Nov. 20 (CNA) Taiwan could buy the COVID-19 vaccine Oxford University is developing with British drugmaker AstraZeneca, a second vaccine showing promising results that the nation will be able to acquire through the COVAX allocation platform, a Central Epidemic Command Center (CECC) official said Friday. According to foreign wire reports, the Oxford-AstraZeneca vaccine shows an "encouraging" immune response in older adults, and 99 percent of the participants in the mid-term clinical trial developed antibodies after taking the shots. The vaccine shows a strong immune response in individuals in their 60s and 70s, raising hopes that it can protect age...
